“The misnomer that drug prices are a primary cause of the health care affordability problem persists, in part, due to the overly complex pricing system for pharmaceuticals,” wrote Wayne Winegarden in the Pacific Research Institute research study.
Although the consumer packaged goods industry is still climbing the sales charts to record heights — the industry reached $797 billion in 2016 — the engines driving that growth are beginning to sputter, according to a report from IRI and Boston Consulting Group.
The continued decline in the number of heavy buyers (those who purchased more than three types of vitamins in a year) was a key trend captured by the 2016 TABS Analytics Vitamin and Minerals Supplements study.
Interest in dietary supplements, sports nutrition, diet aids, meal-replacement solutions and even energy shots has never been higher, according to a Kline consumer survey released last year, particularly among baby boomers.
The bottom line behind President-elect Donald Trump’s proposals: The cost burden of the $3 trillion industry will shift away from the federal government and toward private enterprise, state government and consumers.